Everolimus in Refractory Testicular Germ Cell Cancer
Condition(s):Germ Cell TumorLast Updated:January 12, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Germ Cell TumorLast Updated:January 12, 2016Completed
Condition(s):Metastatic Renal Cell Carcinoma; Failure of Exactly One Prior VEGF-targeted TherapyLast Updated:November 14, 2017Completed
Condition(s):Testicular Cancer; Germ Cell CancerLast Updated:February 25, 2015Completed
Condition(s):Carcinoma; Adenocarcinoma; Renal Cell; Nephroid Carcinoma; HypernephroidLast Updated:March 20, 2017Completed
Condition(s):Kidney Cancer; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:March 3, 2016Completed
Condition(s):Thyroid CancerLast Updated:February 17, 2021Completed
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:February 6, 2019Completed
Condition(s):Breast Cancer MetastaticLast Updated:December 3, 2020Completed
Condition(s):Refractory or Relapsed RMS and Soft Tissue SarcomasLast Updated:March 26, 2013Unknown status
Condition(s):Hepatic InsufficiencyLast Updated:December 21, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.